Palvella Therapeutics's total assets for Q3 2024 were $20.52M, a decrease of -18.08% from the previous quarter. PVLA total liabilities were $4.25M for the fiscal quarter, a -32.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.